跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安卫力 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mobocertinib Succinate Capsules
Approved
化学药品
Mobocertinib Succinate Capsules
Takeda Pharmaceuticals U.S.A., Inc.
🇨🇳 National Medical Products Administration
Approval Date
Jan 10, 2023
Approval ID
3d71905680d262a2
Company
Takeda Pharmaceuticals U.S.A., Inc.
Type
化学药品
Approval Details
Approval Id
3d71905680d262a2
Approval Number
国药准字HJ20230001
Generic Name
琥珀酸莫博赛替尼胶囊
Generic Name En
Mobocertinib Succinate Capsules
Trade Name
安卫力
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
40mg(按C₃₂H₃₉N₇O₄计)
Reg Date
2023-01-10
Expired Date
2028-01-09
Company Name
Takeda Pharmaceuticals U.S.A., Inc.
Company Address
95 Hayden Avenue, Lexington, MA 02421 United States of America
Production Company Name
xcelience, llc
Production Company Address
5415 West Laurel Street, Tampa, Florida (FL) 33607 USA
Company Detail Path
/organization/takeda-pharmaceuticals-u-s-a-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 10, 2023
Approval ID
3d71905680d262a2
Type
化学药品
Back to NMPA Approvals